Athenex, Inc. to Report Third Quarter 2019 Earnings Results on November 7, 2019


You May Also Like

ThromboGenics Business Update – H1 2017

Press release                                                          7 September, 2017Regulated Information Good Progress in Advancing Diabetic Eye Disease Portfolio ...

Progenics Pharmaceuticals to Present at Upcoming Investor Conferences

NEW YORK, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), an ...